These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22333215)

  • 1. Impact of first-line sildenafil monotreatment for pulmonary arterial hypertension.
    Yanagisawa R; Kataoka M; Taguchi H; Kawakami T; Tamura Y; Fukuda K; Yoshino H; Satoh T
    Circ J; 2012; 76(5):1245-52. PubMed ID: 22333215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
    Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB;
    Ann Intern Med; 2008 Oct; 149(8):521-30. PubMed ID: 18936500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension.
    Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost A; Engel P; Kramer MR; Serdarevic-Pehar M; Layton GR; Sitbon O; Badesch DB;
    J Heart Lung Transplant; 2014 Jul; 33(7):689-97. PubMed ID: 24815795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative sildenafil therapy for pulmonary hypertension in infants undergoing congenital cardiac defect closure.
    El Midany AA; Mostafa EA; Azab S; Hassan GA
    Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):963-8. PubMed ID: 23985411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How long can we leave patients with pulmonary arterial hypertension on oral drug monotreatment?
    Ogawa A; Matsubara H
    Circ J; 2012; 76(5):1089-90. PubMed ID: 22466634
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension.
    Vachiery JL; Huez S; Gillies H; Layton G; Hayashi N; Gao X; Naeije R
    Br J Clin Pharmacol; 2011 Feb; 71(2):289-92. PubMed ID: 21219411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summaries for patients. A combination treatment for pulmonary hypertension.
    Ann Intern Med; 2008 Oct; 149(8):I-38. PubMed ID: 18936497
    [No Abstract]   [Full Text] [Related]  

  • 10. "Out of the blue"-safety and efficacy of pulmonary hypertension treatment in childhood*.
    Kraemer U; Wildschuth E; Tibboel D
    Pediatr Crit Care Med; 2014 May; 15(4):377-8. PubMed ID: 24801422
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension.
    Stiebellehner L; Petkov V; Vonbank K; Funk G; Schenk P; Ziesche R; Block LH
    Chest; 2003 Apr; 123(4):1293-5. PubMed ID: 12684325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study.
    Rubin LJ; Badesch DB; Fleming TR; Galiè N; Simonneau G; Ghofrani HA; Oakes M; Layton G; Serdarevic-Pehar M; McLaughlin VV; Barst RJ;
    Chest; 2011 Nov; 140(5):1274-1283. PubMed ID: 21546436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled iloprost plus oral sildenafil in patients with severe pulmonary arterial hypertension delays the need for lung transplantation.
    Lopez-Meseguer M; Berastegui C; Monforte V; Bravo C; Domingo E; Roman A
    Transplant Proc; 2013; 45(6):2347-50. PubMed ID: 23953548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paediatric pulmonary hypertension and sildenafil: current practice and controversies.
    Wardle AJ; Tulloh RM
    Arch Dis Child Educ Pract Ed; 2013 Aug; 98(4):141-7. PubMed ID: 23771819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effect of sildenafil is maintained in pulmonary arterial hypertension patients chronically treated with bosentan.
    Hatano M; Yao A; Kinugawa K; Hirata Y; Nagai R
    Int Heart J; 2011; 52(4):233-9. PubMed ID: 21828950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
    Garg N; Sharma MK; Sinha N
    Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.
    Voswinckel R; Reichenberger F; Enke B; Kreckel A; Krick S; Gall H; Schermuly RT; Grimminger F; Rubin LJ; Olschewski H; Seeger W; Ghofrani HA
    Pulm Pharmacol Ther; 2008 Oct; 21(5):824-32. PubMed ID: 18657627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary study on the efficacy and safety of oral sildenafil in pulmonary arterial hypertension in China].
    Xiong CM; He JG; Lu XL; Shan GL; Wu BX; Zhu XY; Wu GH; Zeng XF; Guo T; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Tian HY; Li WM; Zhang DZ; Zhang C; Li MT; Liu HM; Guo YJ; Shen JY; Zhang WJ; Liu S; Zhou DX; Bao CD; Huang SA; Chen JY; Wu WF; Huang K; Li CL; Wang LH; He B
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):370-4. PubMed ID: 21418907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
    Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with oral sildenafil and beraprost for pulmonary arterial hypertension associated with CREST syndrome.
    Miwa K; Matsubara T; Uno Y; Yasuda T; Sakata K; Tsuda T; Kanaya H
    Int Heart J; 2007 May; 48(3):417-22. PubMed ID: 17592207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.